0 likes | 6 Views
The global self-monitoring blood glucose devices market size was valued at USD 12.82 billion in 2022 and is poised to grow at a significant CAGR of 8.6% during the forecast period 2023-29. It also includes market size and projection estimations for each of the five major regions from 2023 to 2029. The research report includes historical data, trending features, and market growth estimates for the future. Furthermore, the study includes a global and regional estimation and further split by nations and categories within each region. The research also includes factors and barriers to the self-mon
E N D
Market Overview: The Global Self-Monitoring Blood Glucose Devices Market size was valued at USD 12.82 billion in 2022 and is poised to grow at a significant CAGR of 8.6% during the forecast period 2023-29. The Self-Monitoring Blood Glucose Devices Market research report also provides opportunities for business owners to exploit through use of relevant approaches. The study’s prospects assist stakeholders and report purchasers in properly planning their investments and augmenting their profits. The report provides a quantitative analysis of the market segments, trends, estimations, and dynamics of the Self- Monitoring Blood Glucose Devices Market analysis from 2023 to 2029 to identify the prevailing market opportunities. In addition, the report discusses the implications of COVID-19, including the industry's initial response and strategies for ensuring business continuity in the coming years. View Detailed Report Description 2
Market Segments: The Self-Monitoring Blood Glucose Devices Market has been fragmented based on: 1) By Product: Blood Glucose Meter, Blood Glucose Testing Strips, Lancets, Others 2) By End Users: Hospitals, Clinics, Diagnostic Centres, Homecare 3) By Geography: Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe Request Sample Report 3
Key Players: Some of the major key players in the Self-Monitoring Blood Glucose Devices Market are: • • • • • • • • • Abbott Laboratories (U.S.) ARKRAY, Inc. (Japan) Bayer AG (Germany) Dexcom, Inc. (U.S.) Hoffmann-La Roche Ltd (Switzerland) Johnson & Johnson (U.S.) Medtronic plc (U.S.) Nipro Diagnostics, Inc. (U.S.) Terumo Medical Corporation (U.S.) Request Sample Report 4
Europe Office: Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX Asia-Pacific Office: Precision Business Insights, MIG 366, SAI PLAZA, 1st Floor, KPHB Colony, Hyderabad – 500072 Email: sales@precisionbusinessinsights.com Toll-Free: +1-866-598-1553 5